Bain Capital Life Sciences (BCLS) has announced a new fund with approximately $3 billion in total commitments.
The fourth fund for BCLS includes approximately $2.5 billion of outside commitments from existing and new investors.
The fund will invest in medicines, medical devices, diagnostics and life sciences tools.
BCLS, founded in 2016, states that it has raised approximately $6.7 billion and invested in more than 70 companies.
